von Redaktion LCGC | Feb. 15, 2013
Molecular pathology of the lungs. New perspectives by next generation sequencing Vollbrecht C, König K, Heukamp LC, Buettner R, Odenthal M Journal: Der Pathologe, Vol 34, No 1, February 2013. doi: 10.1007/s00292-012-1704-7 Veröffentlichung: Februar...
von Redaktion LCGC | Feb. 15, 2013
Lung Cancer: Molecular pathology and personalized therapy Schultheis A, Wolf J, Buettner J Journal: Der Internist, Vol 54, No 2, February 2013. doi: 10.1007/s00108-012-3151-1 Veröffentlichung: Februar...
von Redaktion LCGC | Jan. 15, 2013
Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib Scheffler M, Zander T, Nogova L, Kobe C, Kahraman D, Dietlein M, Papachristou I, Heukamp LC, Buettner R, Boellard R,...
von Redaktion LCGC | Dez. 15, 2012
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models Zhang J, Zhang L, Su X, Li M, Xie L, Malchers F, Fan S, Yin X, Xu Y, Liu K, Dong Z,Zhu G, Qian Z, Tang L, Zhan P,...
von Redaktion LCGC | Nov. 15, 2012
Genetic insight and therapeutic targets in squamous-cell lung cancer Sos ML, Thomas RK Journal: Oncogene, Vol 31, No 46, November 2012, doi: 10.1038/onc.2011.640Veröffentlichung: November...
